Cathy Burgess is quoted on how the Food and Drug Administration might conduct remote inspections of drug manufacturing facilities amid COVID-19.
In the News
January 5, 2021
Inside Health Policy | FDA Inspection Plans Unclear as EUAs Move toward Full Approvals
Media Contact